Mass Spectrometry: Clinical Trials

67 trials of Mass Spectrometry, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

47 completed, 9 unknown, 7 terminated, 2 withdrawn. 21 Phase 1, 13 Phase 2, 5 Not applicable, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 121Completed 18, Terminated 2, Withdrawn 1
Phase 213Completed 9, Terminated 4
Not applicable5Unknown 3, Completed 1, Terminated 1
Early Phase 11Completed 1

Follow Mass Spectrometry: new trials by email Literature Review of Mass Spectrometry trials Research Report on Mass Spectrometry

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Monitoring MRD in Multiple Myeloma in Serum by Mass Spectrometry
Mass spectrometry - Multiple Myeloma, Minimal Residual Disease
Not yet recruitingOdense University Hospital402026-08-042026-07-08
Histiocytosis in Injecting Drug Users
Chitotriosidase, Mass spectrometry, scanning electron microscope with energy-dispersive X-ray spectroscopy - Histiocytosis
Enrolling by invitationTampere University Hospital302023-05-292025-09-10
Finding New Targets by Proteomic Approaches (InnovRT1)
Mass spectrometry - ATRT
CompletedAssistance Publique - Hôpitaux de Paris442022-08-122026-10-05
Rapid Diagnostic Test for Septic Arthritis
Mass spectrometry - Juvenile Idiopathic Arthritis, Arthritis, Septic
CompletedAssistance Publique - Hôpitaux de Paris2742021-05-062023-01-04
Analysis of Volatile Organic Compounds in Exhaled Air and Sweat: Interest in Rapid Screening for COVID-19 Infection.
Volatile Organic Compounds analysis (e-noses), Canine odor detection of Volatile Organic Compounds, Volatile Organic Compounds analysis (mass spectrometry) - Covid19
Not applicableUnknownHopital Foch1922021-03-012022-08-03
Hepatobiliary Tumors Tissue Samples Acquisition
Gene expression analysis, Genomic analysis, Protein expression analysis - Hepatocellular Carcinoma, Cholangiocarcinoma
UnknownPeking Union Medical College Hospital4502020-10-112023-07-07
Time to Appropriate Antibiotic Between Using Microarray Assay and Mass Spectrometry Technique
Mass spectrometry, Microarray assay - Septicemia
Not applicableUnknownChiang Mai University2002018-07-302018-07-11
Genomic and Proteomic Study of Richter Syndrome (CGPSR)
Whole exome sequencing., RNA sequencing, Mass spectrometry - Richter Syndrome
UnknownCentral Hospital, Nancy, France1702017-09-062023-03-24
Mass Spectrometry in Single Bladder Cancer Cells
mass spectrometry - Bladder Cancer
CompletedUniversity of Oklahoma22017-07-012020-10-19
Embryo Selection by Metabolomic Profiling of Embryo Culture Medium With Mass Spectroscopy as an Adjunct to Morphology
Morphology, Morphology and Mass Spectroscopy - Embryo Selection, IVF
Not applicableUnknownIstanbul University3002016-10-012016-08-30
Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia
mutation analysis, protein analysis, laboratory biomarker analysis - Leukemia
CompletedEastern Cooperative Oncology Group2202012-01-032017-05-19
Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia
gene expression analysis, gene rearrangement analysis, polymerase chain reaction - Leukemia
CompletedChildren's Oncology Group202011-12-012016-05-18
Aurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV Melanoma
laboratory biomarker identification and analysis, biopsy, immunohistochemistry/tissue microarrays - Recurrent Melanoma, Stage IIIc Melanoma
Phase 2TerminatedVanderbilt-Ingram Cancer Center122011-10-012016-05-30
Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma
RNA analysis, polymerase chain reaction, protein expression analysis - Neuroblastoma
CompletedChildren's Oncology Group3002011-06-012016-05-18
Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma
gene expression analysis, immunohistochemistry staining method, laboratory biomarker analysis - Sarcoma
CompletedChildren's Oncology Group602011-06-012016-05-19
Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies
fludarabine phosphate, methoxyamine, laboratory biomarker analysis - Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma
Phase 1CompletedCase Comprehensive Cancer Center202011-05-012015-08-13
Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma
microarray analysis, protein expression analysis, western blotting - Lymphoma
CompletedChildren's Oncology Group72011-05-012016-05-19
Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
bafetinib, microdialysis, pharmacological study - Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma
Phase 1CompletedCity of Hope Medical Center72010-12-012018-04-17
Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
entinostat, imatinib mesylate, laboratory biomarker analysis - Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia
Phase 1 / Phase 2TerminatedNational Cancer Institute (NCI)22010-10-012017-08-08
Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate
panobinostat, everolimus, laboratory biomarker analysis - Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer
Phase 1 / Phase 2TerminatedRoswell Park Cancer Institute262010-03-012022-08-15

Showing 20 of 67. Sign in to see all of them.

Conditions studied

Breast Neoplasms (16)  ·  Carcinoma, Non-Small-Cell Lung (5)  ·  Carcinoma, Ovarian Epithelial (5)  ·  Lung Neoplasms (5)  ·  Brain Neoplasms (4)  ·  Breast Carcinoma In Situ (4)  ·  Carcinoma, Intraductal, Noninfiltrating (4)  ·  Colonic Neoplasms (4)  ·  Colorectal Neoplasms (4)  ·  Head and Neck Neoplasms (4)  ·  Ovarian Neoplasms (4)  ·  Prostatic Neoplasms (4)  ·  Rectal Neoplasms (4)  ·  Squamous Cell Carcinoma of Head and Neck (4)  ·  Carcinoma, Hepatocellular (3)

Sponsors

City of Hope Medical Center (9)  ·  Vanderbilt-Ingram Cancer Center (6)  ·  Children's Oncology Group (4)  ·  Abramson Cancer Center at Penn Medicine (3)  ·  Mayo Clinic (3)  ·  National Cancer Institute (NCI) (3)  ·  Wake Forest University Health Sciences (3)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Barbara Ann Karmanos Cancer Institute (2)  ·  Case Comprehensive Cancer Center (2)  ·  Children's Cancer and Leukaemia Group (2)  ·  Roswell Park Cancer Institute (2)  ·  University of Nebraska (2)  ·  Cancer Research UK (1)  ·  Cancer Trials Ireland (1)

Countries

United States (40)  ·  United Kingdom (5)  ·  France (4)  ·  Ireland (3)  ·  Belgium (1)  ·  Canada (1)  ·  China (1)  ·  Finland (1)  ·  Thailand (1)  ·  Turkey (Türkiye) (1)

Top investigators

Ercole Cavalieri, DSc (2)  ·  Frank M. Torti, MD, MPH (2)  ·  Ravi Amaravadi, MD (2)  ·  A. Bapsi Chakravarthy, MD (1)  ·  Alan Boddy, PhD (1)  ·  Allen E. Bale, MD (1)  ·  Anthony Leathem, MD (1)  ·  Barbara Murphy, MD (1)  ·  Carlos L. Arteaga, MD (1)  ·  Courtney DiNardo, MD (1)  ·  David H. Ilson, MD, PhD (1)  ·  Donald W. Northfeld, MD (1)  ·  Eddy J. Estlin (1)  ·  Edith A. Perez, MD (1)  ·  Elisabeth I. Heath, MD (1)

Results publications

PMID 10676951, PMID 18492108, PMID 20014148, PMID 20368434, PMID 20471824, PMID 21266718, PMID 21285985, PMID 21417856, PMID 21670202, PMID 22044694, PMID 22571487, PMID 23380277, PMID 23841899, PMID 24004666, PMID 24127483, PMID 30167756, PMID 30623229, PMID 31654285, PMID 34000073, PMID 34615429, PMID 36110959, PMID 37863903

NIH funding

P30CA033572 (6), P30CA068485 (3), P30CA012197 (2), P30CA022453 (2), P30CA036727 (2), N01CM62207 (1), N01CN35158 (1), P30CA008748 (1), P30CA014520 (1), P30CA015083 (1), P30CA046592 (1), P30CA082709 (1), P50CA098131 (1), R01CA080195 (1), R21CA204706 (1)